0 Evaluaciones
ID

4503

Descripción

ACNS1123 Eligibility Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Link

https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=

Palabras clave

Versiones (2)
  1. 9/12/13 9/12/13 - Martin Dugas
  2. 2/6/15 2/6/15 -
Subido en

9 de diciembre de 2013

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY-NC 3.0 Legacy
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

  • El más nuevo
  • Más antiguo
  • Popular
  • El más nuevo
    • El más nuevo
    • Más antiguo
    • Popular

    Sin comentarios

    Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

    ACNS1123 Eligibility - 3377519v1.0

    Inglés

    No Instruction available.

    1 formularios  
    1. StudyEvent: SE.0000
      1. No Instruction available.
    Stratification
    Descripción

    Stratification

    ACNS1123 Stratum
    Descripción

    ClinicalStudyACNS1123StratificationFactorsType

    Tipo de datos

    text

    Study Treatment
    Descripción

    TreatmentAssignmentType

    Tipo de datos

    text

    Treatment Begin Date (Projected date must be no later than 5 calendar days after the date of study enrollment. Enter as MM/DD/YYYY.)
    Descripción

    TreatmentBeginDate

    Tipo de datos

    date

    Elig - Block 1
    Descripción

    Elig - Block 1

    Is the patient enrolled on the ALTE07C1 study?
    Descripción

    OtherStudyEnrollmentInd-2

    Tipo de datos

    text

    Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
    Descripción

    PatientAgeEligibilityDeterminationInd-2

    Tipo de datos

    text

    Was definitive diagnostic surgery performed?
    Descripción

    FirstDiagnosisFromSurgicalProcedureIndicator

    Tipo de datos

    text

    Date of definitive diagnostic surgery or clinical diagnosis:
    Descripción

    PersonSuspectedClinicalDiagnosisEligibilityCriteriaDate

    Tipo de datos

    date

    Was lumbar CSF cytology obtained?
    Descripción

    CerebrospinalFluidCellInd-3

    Tipo de datos

    text

    Was it medically contraindicated? (If no,)
    Descripción

    CerebrospinalFluidDiagnosticProcedureCytologyContraindicatedInd-2

    Tipo de datos

    text

    Was lumbar CSF cytology negative?
    Descripción

    LaboratoryProcedureLumbarPunctureCerebrospinalFluidNegativeFindingOutcomeInd-2

    Tipo de datos

    text

    Elig - Block 2
    Descripción

    Elig - Block 2

    Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
    Descripción

    GermCellTumorHistologicClassificationDiagnosisInd-2

    Tipo de datos

    text

    Elig - Block 3
    Descripción

    Elig - Block 3

    Does patient have newly diagnosed localized primary CNS NGGCT?
    Descripción

    NewPrimaryMalignantNeoplasmCentralNervousSystemGermCellTumorDiagnosisInd-2

    Tipo de datos

    text

    Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
    Descripción

    PathologyFindingsIndicator

    Tipo de datos

    text

    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    Descripción

    PatientProtocolRequirementEligibilityDeterminationInd-2

    Tipo de datos

    text

    Elig - Block 4
    Descripción

    Elig - Block 4

    Does patient have newly diagnosed localized primary CNS germinoma?
    Descripción

    NewChildhoodBrainGerminomaDiagnosisInd-2

    Tipo de datos

    text

    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    Descripción

    PatientProtocolRequirementEligibilityDeterminationInd-2

    Tipo de datos

    text

    Elig - Block 5
    Descripción

    Elig - Block 5

    Peripheral absolute neutrophil count (ANC) (number/uL)
    Descripción

    LaboratoryProcedureAbsoluteNeutrophilCountResultSpecifiedValue

    Tipo de datos

    double

    Unidades de medida
    • ul
    ul
    Platelet count (number/uL): (Transfusion Independent)
    Descripción

    LaboratoryProcedurePlateletResultSpecifiedValue

    Tipo de datos

    double

    Unidades de medida
    • 1000/uL
    1000/uL
    Hemoglobin(g/dL) (May receive RBC transfusion)
    Descripción

    LaboratoryProcedureHemoglobinResultSpecifiedValue

    Tipo de datos

    double

    Unidades de medida
    • g/dL
    g/dL
    Elig - Block 5
    Descripción

    Elig - Block 5

    Creatinine clearance (mL/min/1.73m²):
    Descripción

    LaboratoryProcedureCreatinineClearanceOutcomeValue

    Tipo de datos

    double

    Radioisotope GFR(mL/min/1.73 m²)
    Descripción

    LaboratoryProcedureGlomerularFiltrationRateOutcomeSpecifiedValue

    Tipo de datos

    double

    Unidades de medida
    • mL/Min/1.73m2
    mL/Min/1.73m2
    Serum creatinine (mg/dL) (At study entry and based on age/gender per protocol section 3.2.5.2)
    Descripción

    LaboratoryProcedureCreatinineResultSpecifiedValue

    Tipo de datos

    double

    Unidades de medida
    • mg/dL
    mg/dL
    Elig - Block 7
    Descripción

    Elig - Block 7

    Total bilirubin (mg/dl), ULN
    Descripción

    LaboratoryProcedureTotalBilirubinResultSpecifiedUpperLimitofNormalValue

    Tipo de datos

    double

    Unidades de medida
    • mg/dL
    mg/dL
    Total bilirubin Value (mg/dl):
    Descripción

    LaboratoryProcedureTotalBilirubinResultValue

    Tipo de datos

    double

    Unidades de medida
    • mg/dL
    mg/dL
    SGPT (ALT) or SGOT (AST) U/L, ULN:
    Descripción

    LaboratoryProcedureSerumGlutamicPyruvicTransaminaseResultUpperLimitofNormalValue

    Tipo de datos

    double

    SGPT (ALT) or SGOT (AST), U/L
    Descripción

    LaboratoryProcedureAlanineAminotransferaseMeasurementAspartateAminotransferaseMeasurementOutcomeValue

    Tipo de datos

    double

    Elig - Block 8
    Descripción

    Elig - Block 8

    Does patient have seizure disorder?
    Descripción

    PatientSeizureDiseaseorDisorderInd-3

    Tipo de datos

    text

    Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
    Descripción

    NeurologicalEvaluationSeizureSymptomInd-2

    Tipo de datos

    text

    Is patient in status, coma or assisted ventilation at study entry?
    Descripción

    PatientMechanicalVentilationUseInd-2

    Tipo de datos

    text

    Elig - Block 9
    Descripción

    Elig - Block 9

    Does patient have mature teratoma with normal tumor markers?
    Descripción

    PatientCentralNervousSystemGermCellTumorDiagnosisInd-2

    Tipo de datos

    text

    Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
    Descripción

    ExternalBrainVentricleCentralNervousSystemGermCellTumorDiagnosisInd-2

    Tipo de datos

    text

    Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
    Descripción

    MetastaticDiseaseorDisorderMagneticResonanceImagingCerebrospinalFluidDiagnosisInd-2

    Tipo de datos

    text

    Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
    Descripción

    SurgicalInterventionCorticosteroidAdministeredInd-2

    Tipo de datos

    text

    Is patient post menarcheal?
    Descripción

    PediatricEndocrineMensesOnsetInd-2

    Tipo de datos

    text

    Was a pregnancy test performed?
    Descripción

    PatientPregnancyTestIndicator

    Tipo de datos

    text

    Is patient pregnant? (If yes above,)
    Descripción

    PatientPregnancyInd-2

    Tipo de datos

    text

    Is patient nursing?
    Descripción

    PersonBreastFeedingExclusionCriteriaIndicator

    Tipo de datos

    text

    Has patient agreed to stop breastfeeding? (If yes above,)
    Descripción

    BreastFeedingStopAgreementInd-4

    Tipo de datos

    text

    Has patient agreed to use an effective contraceptive method for the duration of the study participation?
    Descripción

    ContraceptionAgreementInd

    Tipo de datos

    text

    Elig - Block 10
    Descripción

    Elig - Block 10

    Date Informed Consent Signed
    Descripción

    InformedConsentFormSignedDate

    Tipo de datos

    date

    Have all institutional, FDA, and NCI requirements for human studies been met?
    Descripción

    StudyCompleteRequirementsInd-2

    Tipo de datos

    text

    Comments
    Descripción

    ResearchCommentsText

    Tipo de datos

    text

    Volver a la parte superior de la página

    Similar models

    No Instruction available.

    1 formularios
    1. StudyEvent: SE.0000
      1. No Instruction available.
    Name
    Tipo
    Description | Question | Decode (Coded Value)
    Tipo de datos
    Alias
    Item Group
    Stratification
    CL.1
    Code List
    ACNS1123 Stratum
    CL Item
    Stratum 1 - Nggct (Stratum 1 - NGGCT)
    CL Item
    Stratum 2 - Germinoma (Stratum 2 - Germinoma)
    Item
    Study Treatment
    text
    CL.2
    Code List
    Study Treatment
    CL Item
    Treatment 1: A,b,a,b,a,b (Treatment 1 A B A B A B)
    CL Item
    Treatment 2: A,a,a,a (Treatment 2 A A A A)
    TreatmentBeginDate
    Item
    Treatment Begin Date (Projected date must be no later than 5 calendar days after the date of study enrollment. Enter as MM/DD/YYYY.)
    date
    Item Group
    Elig - Block 1
    Item
    Is the patient enrolled on the ALTE07C1 study?
    text
    CL.3
    Code List
    Is the patient enrolled on the ALTE07C1 study?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
    text
    CL.4
    Code List
    Is the patient greater than or equal to 3 years and less than or equal to 21 years at the time of enrollment?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Was definitive diagnostic surgery performed?
    text
    CL.5
    Code List
    Was definitive diagnostic surgery performed?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    PersonSuspectedClinicalDiagnosisEligibilityCriteriaDate
    Item
    Date of definitive diagnostic surgery or clinical diagnosis:
    date
    Item
    Was lumbar CSF cytology obtained?
    text
    CL.6
    Code List
    Was lumbar CSF cytology obtained?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Was it medically contraindicated? (If no,)
    text
    CL.7
    Code List
    Was it medically contraindicated? (If no,)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    CL.8
    Code List
    Was lumbar CSF cytology negative?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item Group
    Elig - Block 2
    Item
    Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
    text
    CL.9
    Code List
    Does patient have germ cell tumor(s) located in the suprasellar, pineal, bifocal (pineal + suprasellar) or ventricles? (Tumors present in the above mentioned locations and with unifocal parenchymal extension)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item Group
    Elig - Block 3
    Item
    Does patient have newly diagnosed localized primary CNS NGGCT?
    text
    CL.10
    Code List
    Does patient have newly diagnosed localized primary CNS NGGCT?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
    text
    CL.11
    Code List
    Does patient have any of the following elements on biopsy/resection? (endodermal sinus tumor yolk sacor embryonal carcinoma or choriocarcinoma or malignant/immature teratoma or mixed GCT with malignant GCT elements)
    CL Item
    Yes (YES)
    CL Item
    No (NO)
    Item
    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    text
    CL.14
    Code List
    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Does patient have newly diagnosed localized primary CNS germinoma?
    text
    CL.13
    Code List
    Does patient have newly diagnosed localized primary CNS germinoma?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    text
    CL.14
    Code List
    Does patient meet any of the following criteria: (Institutional normal AFP and hCGB 5mIU/mL - <= 50mIU/mL in serum and/or CSF or Bifocal pineal + suprasellar involvement or pineal lesion with diabetes insipidus DI AND hCGB<=100mIU/mL and institutional normal AFP in serum/or CSF or Histologically confirmed germinoma mixed with mature teratoma and hCGB <= 100mIU/mL and institutional normal AFP in serum/or CSF.)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    LaboratoryProcedureAbsoluteNeutrophilCountResultSpecifiedValue
    Item
    Peripheral absolute neutrophil count (ANC) (number/uL)
    double
    LaboratoryProcedurePlateletResultSpecifiedValue
    Item
    Platelet count (number/uL): (Transfusion Independent)
    double
    LaboratoryProcedureHemoglobinResultSpecifiedValue
    Item
    Hemoglobin(g/dL) (May receive RBC transfusion)
    double
    LaboratoryProcedureCreatinineClearanceOutcomeValue
    Item
    Creatinine clearance (mL/min/1.73m²):
    double
    LaboratoryProcedureGlomerularFiltrationRateOutcomeSpecifiedValue
    Item
    Radioisotope GFR(mL/min/1.73 m²)
    double
    LaboratoryProcedureCreatinineResultSpecifiedValue
    Item
    Serum creatinine (mg/dL) (At study entry and based on age/gender per protocol section 3.2.5.2)
    double
    LaboratoryProcedureTotalBilirubinResultSpecifiedUpperLimitofNormalValue
    Item
    Total bilirubin (mg/dl), ULN
    double
    LaboratoryProcedureTotalBilirubinResultValue
    Item
    Total bilirubin Value (mg/dl):
    double
    LaboratoryProcedureSerumGlutamicPyruvicTransaminaseResultUpperLimitofNormalValue
    Item
    SGPT (ALT) or SGOT (AST) U/L, ULN:
    double
    LaboratoryProcedureAlanineAminotransferaseMeasurementAspartateAminotransferaseMeasurementOutcomeValue
    Item
    SGPT (ALT) or SGOT (AST), U/L
    double
    Item Group
    Elig - Block 8
    Item
    Does patient have seizure disorder?
    text
    CL.15
    Code List
    Does patient have seizure disorder?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
    text
    CL.16
    Code List
    Is patient's seizure disorder well controlled? (Adequate central nervous system function as defined in protocol section 3.2.5.4)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Is patient in status, coma or assisted ventilation at study entry?
    text
    CL.17
    Code List
    Is patient in status, coma or assisted ventilation at study entry?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item Group
    Elig - Block 9
    Item
    Does patient have mature teratoma with normal tumor markers?
    text
    CL.18
    Code List
    Does patient have mature teratoma with normal tumor markers?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
    text
    CL.19
    Code List
    Does patient have tumors located outside the ventricles? (basal ganglia, thalamus)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
    text
    CL.20
    Code List
    Does patient have metastatic disease by either MRI evaluation or lumbar CSF cytology?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
    text
    CL.21
    Code List
    Prior to study enrollment, has patient been treated with therapy other than surgical intervention and corticosteroids?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Is patient post menarcheal?
    text
    CL.22
    Code List
    Is patient post menarcheal?
    CL Item
    Yes (yes)
    CL Item
    No (no)
    Item
    Was a pregnancy test performed?
    text
    CL.23
    Code List
    Was a pregnancy test performed?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Is patient pregnant? (If yes above,)
    text
    CL.24
    Code List
    Is patient pregnant? (If yes above,)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    CL.25
    Code List
    Is patient nursing?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Has patient agreed to stop breastfeeding? (If yes above,)
    text
    CL.26
    Code List
    Has patient agreed to stop breastfeeding? (If yes above,)
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    Item
    Has patient agreed to use an effective contraceptive method for the duration of the study participation?
    text
    CL.27
    Code List
    Has patient agreed to use an effective contraceptive method for the duration of the study participation?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    CL Item
    N/a, Patient Is Not Of Reproductive Potential (NA patient is not of reproductive potential)
    Item Group
    Elig - Block 10
    InformedConsentFormSignedDate
    Item
    Date Informed Consent Signed
    date
    Item
    Have all institutional, FDA, and NCI requirements for human studies been met?
    text
    CL.28
    Code List
    Have all institutional, FDA, and NCI requirements for human studies been met?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    ResearchCommentsText
    Item
    Comments
    text
    Volver a la parte superior de la página 

    Ayuda

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial